Assessment of Quality of Life in the Treatment of Patients with Neuropathic Fecal Incontinence
Overview
Affiliations
Introduction: Development of quality-of-life measures has been the focus of research in colorectal disorders in recent years. The assessment of quality of life for fecal incontinence should be more important than quantitative measurement of soiling.
Purpose: This study assesses specific patient quality-of-life objectives, categorizes objectives, and correlates these objectives with continence scores.
Methods: One hundred eighteen patients entered into a randomized, controlled trial of biofeedback were assessed using the Direct Questioning of Objectives quality-of-life measure. All objectives were documented, categorized, and correlated with continence scores and analog scales.
Results: In patients with neuropathic fecal incontinence, the most frequent quality-of-life group concerned the ability to get out of home, to socialize outside of home, to go shopping, and not to have to worry about the location of the nearest toilet while out of home (34 percent; 123/364). At least one of these four objectives was stated by 72 percent of patients (85/118). Only 31 percent of patients (37/118) nominated an objective related to the physical act of soiling. The ability to travel (29 percent), exercise including walking (25 percent), perform home duties (19 percent), family and relationships (22 percent), and job (13 percent) were less frequently cited by patients.
Conclusion: Continence scores focus heavily on the physical aspects of incontinence such as soiling and hygiene, aspects which seem to be less important to the patients themselves. It is important, therefore, that assessments of fecal incontinence should include reference to quality of life, and in particular to its impact on activities relating to "getting out of the house."
Todd C, Johnson E, Stewart F, Wallace S, Bryant A, Woodward S Cochrane Database Syst Rev. 2024; 10:CD002115.
PMID: 39470206 PMC: 11520510. DOI: 10.1002/14651858.CD002115.pub6.
Karunaratne S, Harris I, Horsley M, Trevena L, Solomon M J Patient Rep Outcomes. 2024; 8(1):56.
PMID: 38842595 PMC: 11156622. DOI: 10.1186/s41687-024-00734-8.
Zheng C, Yang Z, Kong L, Gao Z, Lu T, Zhang H BMC Public Health. 2023; 23(1):1345.
PMID: 37438713 PMC: 10339609. DOI: 10.1186/s12889-023-16231-4.
Johns J, Krogh K, Rodriguez G, Eng J, Haller E, Heinen M Top Spinal Cord Inj Rehabil. 2021; 27(2):75-151.
PMID: 34108835 PMC: 8152174. DOI: 10.46292/sci2702-75.
Johns J, Krogh K, Rodriguez G, Eng J, Haller E, Heinen M J Spinal Cord Med. 2021; 44(3):442-510.
PMID: 33905316 PMC: 8115581. DOI: 10.1080/10790268.2021.1883385.